High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition

被引:12
作者
Krishna, Shagun [1 ]
Borrel, Alexandre [2 ]
Huang, Ruili [3 ]
Zhao, Jinghua [3 ]
Xia, Menghang [3 ]
Kleinstreuer, Nicole [1 ]
机构
[1] NIEHS, Div Natl Toxicol Program, Res Triangle Pk, NC 27560 USA
[2] Silent Spring Inst, Newton, MA 02460 USA
[3] Natl Ctr Adv Translat Sci NCATS, Div Preclin Innovat, Bethesda, MD 20892 USA
来源
BIOLOGY-BASEL | 2022年 / 11卷 / 02期
基金
美国国家卫生研究院;
关键词
cardiovascular; hERG; Tox21 high-throughput screening; environmental chemicals; in silico modeling; QSAR models; POTASSIUM CHANNEL BLOCKAGE; CARDIAC-ARRHYTHMIA; DRUGS; DISINFECTANTS; PROLONGATION; TERFENADINE; MECHANISM; AFFINITY; INTERVAL; BROMIDE;
D O I
10.3390/biology11020209
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary Cardiovascular disease is the leading cause of death for people of most ethnicities in the United States. The human ether-a-go-go-related gene (hERG) potassium channel plays a pivotal role in cardiac rhythm regulation, and cardiotoxicity associated with hERG inhibition by drug molecules and environmental chemicals is a major public health concern. An evaluation of the effect of environmental chemicals on hERG channel function can help inform the potential public health risks of these compounds. To assess the cardiotoxic effect of diverse drugs and environmental compounds, the Tox21 federal research program has screened a collection of 9667 chemicals for inhibitory activity against the hERG channel. A set of molecular descriptors covering physicochemical and structural properties of chemicals, self-organizing maps, and hierarchical clustering were applied to characterize the chemicals inhibiting hERG. Machine learning approaches were applied to build robust statistical models that can predict the probability of any new chemical to cause cardiotoxicity via this mechanism. Chemical inhibition of the human ether-a -go-go-related gene (hERG) potassium channel leads to a prolonged QT interval that can contribute to severe cardiotoxicity. The adverse effects of hERG inhibition are one of the principal causes of drug attrition in clinical and pre-clinical development. Preliminary studies have demonstrated that a wide range of environmental chemicals and toxicants may also inhibit the hERG channel and contribute to the pathophysiology of cardiovascular (CV) diseases. As part of the US federal Tox21 program, the National Center for Advancing Translational Science (NCATS) applied a quantitative high throughput screening (qHTS) approach to screen the Tox21 library of 10,000 compounds (~7871 unique chemicals) at 14 concentrations in triplicate to identify chemicals perturbing hERG activity in the U2OS cell line thallium flux assay platform. The qHTS cell-based thallium influx assay provided a robust and reliable dataset to evaluate the ability of thousands of drugs and environmental chemicals to inhibit hERG channel protein, and the use of chemical structure-based clustering and chemotype enrichment analysis facilitated the identification of molecular features that are likely responsible for the observed hERG activity. We employed several machine-learning approaches to develop QSAR prediction models for the assessment of hERG liabilities for drug-like and environmental chemicals. The training set was compiled by integrating hERG bioactivity data from the ChEMBL database with the Tox21 qHTS thallium flux assay data. The best results were obtained with the random forest method (~92.6% balanced accuracy). The data and scripts used to generate hERG prediction models are provided in an open-access format as key in vitro and in silico tools that can be applied in a translational toxicology pipeline for drug development and environmental chemical screening.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Identification of functional sgRNA mutants lacking canonical secondary structure using high-throughput FACS screening
    Liang, Zeyu
    Huang, Chaoyong
    Xia, Yan
    Ye, Zhaojin
    Fan, Shunhua
    Zeng, Junwei
    Guo, Shuyuan
    Ma, Xiaoyan
    Sun, Lichao
    Huo, Yi-Xin
    CELL REPORTS, 2024, 43 (06):
  • [42] Mitigating hERG Liability of Toll-Like Receptor 9 and 7 Antagonists through Structure-Based Design
    Das, Nirmal
    Bhattacharya, Debomita
    Bandopadhyay, Purbita
    Dastidar, Uddipta Ghosh
    Paul, Barnali
    Rahaman, Oindrila
    Hoque, Israful
    Patra, Binita
    Ganguly, Dipyaman
    Talukdar, Arindam
    CHEMMEDCHEM, 2023, 18 (12)
  • [43] Chemical structure-based design of triboelectric materials for high-performance TENGs
    Shang, Yingshuang
    Wang, Zhaoyang
    Yu, Chang
    Xu, Wenhan
    Chen, Zheng
    Jiang, Bo
    Zhang, Haibo
    NANO ENERGY, 2022, 103
  • [44] Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling
    Nyffeler, Johanna
    Willis, Clinton
    Lougee, Ryan
    Richard, Ann
    Paul-Friedman, Katie
    Harrill, Joshua A.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 389
  • [45] Model for High-Throughput Screening of Multitarget Drugs in Chemical Neurosciences: Synthesis, Assay, and Theoretic Study of Rasagiline Carbamates
    Alonso, Nerea
    Caamano, Olga
    Romero-Duran, Francisco J.
    Luan, Feng
    Cordeiro, M. Natalia D. S.
    Yanez, Matilde
    Gonzalez-Diaz, Humberto
    Garcia-Mera, Xerardo
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (10): : 1393 - 1403
  • [46] Evaluation and calibration of high-throughput predictions of chemical distribution to tissues
    Pearce, Robert G.
    Setzer, R. Woodrow
    Davis, Jimena L.
    Wambaugh, John F.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (06) : 549 - 565
  • [47] Identification of PARN nuclease activity inhibitors by computational-based docking and high-throughput screening
    Huynh, Thao Ngoc
    Shukla, Siddharth
    Reigan, Philip
    Parker, Roy
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform
    Shukla, Sunita J.
    Huang, Ruili
    Austin, Christopher P.
    Xia, Menghang
    DRUG DISCOVERY TODAY, 2010, 15 (23-24) : 997 - 1007
  • [49] High-Throughput Screening of Metal Organic Frameworks for Macroscale Heteroepitaxial Alignment
    Tarzia, Andrew
    Takahashi, Masahide
    Falcaro, Paolo
    Thornton, Aaron W.
    Doonan, Christian J.
    Huang, David M.
    ACS APPLIED MATERIALS & INTERFACES, 2018, 10 (47) : 40938 - 40950
  • [50] Development of a high-throughput in vivo screening platform for particulate matter exposures
    Roper, Courtney
    Simonich, Staci L. Massey
    Tanguay, Robert L.
    ENVIRONMENTAL POLLUTION, 2018, 235 : 993 - 1005